Catalyst Wire Dossier Catalyst Wire Dossier

HLA haploidentical peripheral blood mononuclear cell infusion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLA haploidentical peripheral blood mononuclear cell infusion, covering 2016-02-25 to 2016-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML) [Phase 1, Phase 2]

See pricing